erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
.
"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said..
a genetic disorder that leads to underdeveloped sweat glands and teeth was treated in the womb.